Rivaroxaban

Rivaroxaban

A specific inhibitor of FXa is XARELTO. It can function without a cofactor like anti-thrombin III. Free FXa and prothrombinase activity are both inhibited by rivaroxaban. Although rivaroxaban does not directly affect platelet aggregation, it does indirectly prevent thrombin-induced platelet aggregation. The production of thrombin is reduced by rivaroxaban’s inhibition of FXa.

*Products will not be offered for sale in countries where valid Patents are in force.
* It is the responsibility of the buyer to comply with the above.